NO152007C - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer

Info

Publication number
NO152007C
NO152007C NO772431A NO772431A NO152007C NO 152007 C NO152007 C NO 152007C NO 772431 A NO772431 A NO 772431A NO 772431 A NO772431 A NO 772431A NO 152007 C NO152007 C NO 152007C
Authority
NO
Norway
Prior art keywords
sulphalkyltetrazol
oxyymino
cphem
arylacetamido
7beta
Prior art date
Application number
NO772431A
Other languages
English (en)
Norwegian (no)
Other versions
NO152007B (no
NO772431L (no
Inventor
George Lawrence Dunn
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of NO772431L publication Critical patent/NO772431L/no
Publication of NO152007B publication Critical patent/NO152007B/no
Publication of NO152007C publication Critical patent/NO152007C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO772431A 1976-07-12 1977-07-08 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer NO152007C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/704,160 US4066762A (en) 1976-07-12 1976-07-12 Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Publications (3)

Publication Number Publication Date
NO772431L NO772431L (no) 1978-01-13
NO152007B NO152007B (no) 1985-04-09
NO152007C true NO152007C (no) 1985-07-17

Family

ID=24828339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772431A NO152007C (no) 1976-07-12 1977-07-08 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer

Country Status (25)

Country Link
US (1) US4066762A (es)
JP (1) JPS539792A (es)
AR (1) AR218454A1 (es)
AT (1) AT359187B (es)
AU (1) AU506092B2 (es)
BE (1) BE856636A (es)
CA (1) CA1120924A (es)
CH (1) CH628902A5 (es)
DE (1) DE2730377A1 (es)
DK (1) DK304977A (es)
ES (1) ES460595A1 (es)
FI (1) FI63586C (es)
FR (1) FR2361404A1 (es)
GB (1) GB1589094A (es)
HU (1) HU179586B (es)
IE (1) IE45452B1 (es)
IL (1) IL52466A (es)
LU (1) LU77711A1 (es)
MX (1) MX4972E (es)
NL (1) NL7707694A (es)
NO (1) NO152007C (es)
PH (1) PH13412A (es)
PT (1) PT66766B (es)
SE (1) SE437833B (es)
ZA (1) ZA773457B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US4171433A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Amino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporin intermediates for preparing 7-acylamino cephalosporins
IL50546A (en) * 1975-10-30 1980-07-31 Smithkline Corp 7-acyl-3-(1-(2-sulfaminoethyl)tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions containing them
US4171368A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4101656A (en) * 1976-07-12 1978-07-18 Smithkline Corporation 7β-Acylamino-3-(alkanesulfonamidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
FR2421907A1 (fr) * 1978-04-07 1979-11-02 Roussel Uclaf Nouvelles cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl)2-(carboxymethoxyimino/acetamido 3-substitue cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS55133385A (en) * 1979-04-03 1980-10-17 Fujisawa Pharmaceut Co Ltd Novel cephem compound, its preparation, and remedy and preventive against microbism
SE434638B (sv) * 1980-06-06 1984-08-06 Lekemedelsfabriken Medica Ab Nya terapeutiska verdefulla taurinderivat och deras framstellning
US4308267A (en) * 1980-07-03 1981-12-29 Smithkline Corporation 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins
JPH0529868Y2 (es) * 1987-02-10 1993-07-30
JPS63134725U (es) * 1987-02-26 1988-09-05
CN105884666A (zh) * 2010-01-27 2016-08-24 三菱丽阳株式会社 新型链转移剂以及使用该链转移剂的乳液聚合

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL173169C (nl) * 1969-10-27 1983-12-16 Fujisawa Pharmaceutical Co Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking en werkwijze voor het bereiden van het daarvoor benodigde cephalosporinederivaat.
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids
US3966717A (en) * 1971-05-14 1976-06-29 Glaxo Laboratories Limited 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof
US3812110A (en) * 1972-02-24 1974-05-21 Squibb & Sons Inc 7-(1,4-cyclohexadienyl-acylamino)cephalosporins
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
HU172234B (hu) * 1973-12-21 1978-07-28 Glaxo Lab Ltd Sposob poluchenija novykh proizvodnykh 7-beta-acilamido-cef-3-em-4-karbonovojj kisloty
BE832725A (fr) * 1974-09-03 1976-02-25 Nouveaux composes meterocycliques et composition pharmaceutique les contenant
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
IE44607B1 (en) * 1975-03-18 1982-01-27 Smithkline Corp Cephalosporin compounds

Also Published As

Publication number Publication date
NO152007B (no) 1985-04-09
AT359187B (de) 1980-10-27
US4066762A (en) 1978-01-03
PT66766B (en) 1978-12-15
ATA495577A (de) 1980-03-15
IE45452L (en) 1978-01-12
CA1120924A (en) 1982-03-30
PH13412A (en) 1980-03-28
ZA773457B (en) 1978-04-26
SE7708048L (sv) 1978-01-13
HU179586B (en) 1982-11-29
DE2730377A1 (de) 1978-01-19
MX4972E (es) 1983-01-26
AR218454A1 (es) 1980-06-13
AU2694177A (en) 1979-01-18
NO772431L (no) 1978-01-13
ES460595A1 (es) 1978-05-01
BE856636A (fr) 1978-01-09
AU506092B2 (en) 1979-12-13
JPS539792A (en) 1978-01-28
JPS6156239B2 (es) 1986-12-01
GB1589094A (en) 1981-05-07
IL52466A0 (en) 1977-10-31
PT66766A (en) 1977-08-01
LU77711A1 (es) 1977-10-05
IL52466A (en) 1980-06-30
CH628902A5 (de) 1982-03-31
IE45452B1 (en) 1982-08-25
FI772147A (es) 1978-01-13
SE437833B (sv) 1985-03-18
FI63586C (fi) 1983-07-11
FR2361404A1 (fr) 1978-03-10
DK304977A (da) 1978-01-13
FR2361404B1 (es) 1980-11-28
NL7707694A (nl) 1978-01-16
FI63586B (fi) 1983-03-31

Similar Documents

Publication Publication Date Title
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO823274L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkanforbindelser
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO152007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO152787C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner.
NO151410C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(2-klorethyl)-n-nitrosourea-forbindelser
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO145843C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser